Changshan Pharmaceutical announced that the company's board of directors recently received a resignation report from Chairman and General Manager Gao Xiaodong. Gao Xiaodong resigned as general manager due to a job adjustment application. The resignation application took effect on the date it was delivered to the board of directors, and he still served as the company's chairman and chairman of the Strategy Committee after his resignation. Up to now, Gao Xiaodong holds 1.53 million shares of the company's shares. The company held the 9th meeting of the 6th board of directors on September 7, 2026 to review and approve the authorization of Deputy General Manager Chang Yanlu to act as general manager. The period starts from the date the board of directors deliberates and approves until the date the board of directors appoints a new general manager.

Changshan Pharmaceutical announced that the company's board of directors recently received a resignation report from Chairman and General Manager Gao Xiaodong. Gao Xiaodong resigned as general manager due to a job adjustment application. The resignation application took effect on the date it was delivered to the board of directors, and he still served as the company's chairman and chairman of the Strategy Committee after his resignation. Up to now, Gao Xiaodong holds 1.53 million shares of the company's shares. The company held the 9th meeting of the 6th board of directors on September 7, 2026 to review and approve the authorization of Deputy General Manager Chang Yanlu to act as general manager. The period starts from the date the board of directors deliberates and approves until the date the board of directors appoints a new general manager.